4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
European Network for the Study of Adrenal Tumours - Structuring clinical research on adrenal cancers in adults (ENS@T-CANCER)
Date du début: 1 janv. 2011, Date de fin: 30 juin 2016,
Among patients with adrenal masses Adrenocortical carcinoma (ACC) and malignant pheochromocytomas (MPH) are found with a low incidence but very unfavorable prognosis. Due to this poor clinical outcome, concomitant hormone dysregulation and limited treatment options the two cancer entities severely impact on affected patients. However, the rarity of the tumors also impedes clinical studies which ar ...
Voir le projet
17
Participants partenaires
TERMINÉ
The European Network for Translational Research in Atrial Fibrillation (EUTRAF)
Date du début: 1 nov. 2010, Date de fin: 31 oct. 2015,
"The initiation and perpetuation of atrial fibrillation (AF) can be regarded as a complication of a progressive transformation of the structure and functional properties of the atria. This transformation is the result of complex and multiple changes at the molecular, cellular and organ levels which interact to form the basis for proarrhythmic mechanisms in AF. Numerous individual and environmental ...
Voir le projet
20
Participants partenaires
TERMINÉ
ScalPL : A Scalable Programming Language (ScalPL)
Date du début: 1 oct. 2008, Date de fin: 30 sept. 2014,
"The goal of this project is the development of a growable programming language: a language whose vocabulary can easily be extended for purposes such as the development of domain-specific languages. The proposal addresses the long-standing ""holy grail"" of programming: Removing the ""representational gap"", making a program look like a description of a domain expert. This project is certainly not ...
Voir le projet
2
Participants partenaires
TERMINÉ
Targeting the tumour microenvironment to improve pancreatic cancer prognosis (EPC-TM-Net)
Date du début: 1 févr. 2011, Date de fin: 31 juil. 2014,
Pancreatic cancer is one of the most lethal human cancers with a five-year survival rate of less than 5%. Late presentation and a high level of resistance to chemotherapeutic drugs are among the major reasons for this dismal prognosis. The presence of the highest degree of desmoplasia among all solid tumours and the fact that chronic inflammatory pancreatic disease is associated with an increased ...
Voir le projet